---
title: "Guangxi Wuzhou Zhongheng Gets China Supplementary Approval for Antibiotic"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267770326.md"
description: "Guangxi Wuzhou Zhongheng Gets China Supplementary Approval for Antibiotic"
datetime: "2025-11-28T05:05:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267770326.md)
  - [en](https://longbridge.com/en/news/267770326.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267770326.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/267770326.md) | [繁體中文](https://longbridge.com/zh-HK/news/267770326.md)


# Guangxi Wuzhou Zhongheng Gets China Supplementary Approval for Antibiotic



### Related Stocks

- [Zhongheng Group (600252.CN)](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives](https://longbridge.com/en/news/278175869.md)
- [Alibaba Forms Task Force to Accelerate AI Model Development After Qwen Head Exit](https://longbridge.com/en/news/278013047.md)
- [08:36 ETMaryland Approves Asynt Solutions' Ape Barrier® for Use on Roads and Bridges](https://longbridge.com/en/news/277474642.md)
- [Yixin Group Sets Out Board and Committee Structure to Strengthen Governance](https://longbridge.com/en/news/277924457.md)
- [CATL's battery swap ecosystem expands as GAC and BAIC set to launch new models](https://longbridge.com/en/news/278033823.md)